{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:00:44Z","timestamp":1788904844753,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001860"],"award-info":[{"award-number":["UL1 TR001860"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajo.2024.11.022","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T17:54:07Z","timestamp":1733421247000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Suprachoroidal Triamcinolone Acetonide for Noninfectious Uveitis: Real-World Impact on Clinical Outcomes"],"prefix":"10.1016","volume":"271","author":[{"given":"Ketaki","family":"Panse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-8568","authenticated-orcid":false,"given":"Sapna","family":"Gangaputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sili","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-9383","authenticated-orcid":false,"given":"Jeffrey","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Emami-Naeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-3310","authenticated-orcid":false,"given":"GLENN","family":"YIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-9594","authenticated-orcid":false,"given":"KAREEM","family":"MOUSSA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5-6","key":"10.1016\/j.ajo.2024.11.022_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.11.022_bib0002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.11.022_bib0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1076\/ocii.11.1.29.15582","article-title":"Cystoid macular edema in uveitis","volume":"11","author":"Okhravi","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.ajo.2024.11.022_bib0004","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ophtha.2023.04.011","article-title":"Intravitreal therapy for uveitic macular edema-ranibizumab versus methotrexate versus the dexamethasone implant: the MERIT trial results","volume":"130","author":"Acharya","year":"2023","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2024.11.022_bib0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2024.11.022_bib0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/IIO.0000000000000251","article-title":"Medical and surgical applications for the suprachoroidal space","volume":"59","author":"Emami-Naeini","year":"2019","journal-title":"Int Ophthalmol Clin"},{"issue":"10","key":"10.1016\/j.ajo.2024.11.022_bib0007","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamaophthalmol.2023.3785","article-title":"In-office suprachoroidal viscopexy for rhegmatogenous retinal detachment repair","volume":"141","author":"Muni","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2024.11.022_bib0008","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"10.1016\/j.ajo.2024.11.022_bib0009","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2024.11.022_bib0010","first-page":"1139","article-title":"Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)","volume":"106","author":"Khurana","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.022_bib0011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10792-008-9263-x","article-title":"Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis)","volume":"30","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2024.11.022_bib0012","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (An AOS Thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.022_bib0013","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ajo.2012.05.019","article-title":"Wide-field retinal imaging in the management of noninfectious posterior uveitis","volume":"154","author":"Campbell","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.022_bib0014","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.oret.2017.01.016","article-title":"Peripheral findings and retinal vascular leakage on ultra-widefield fluorescein angiography in patients with uveitis","volume":"1","author":"Pecen","year":"2017","journal-title":"Ophthalmol Retina"},{"issue":"11","key":"10.1016\/j.ajo.2024.11.022_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.9.11.27","article-title":"Clinical characterization of suprachoroidal injection procedure utilizing a microinjector across three retinal disorders","volume":"9","author":"Wan","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2024.11.022_bib0016","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.ijg.0000212220.42675.c5","article-title":"Central corneal thickness is not related to anterior scleral thickness or axial length","volume":"15","author":"Oliveira","year":"2006","journal-title":"J Glaucoma"},{"issue":"9","key":"10.1016\/j.ajo.2024.11.022_bib0017","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ophtha.2015.05.033","article-title":"Correlation of serial scleral and corneal pneumatonometry","volume":"122","author":"Kuo","year":"2015","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424005543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424005543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:05:08Z","timestamp":1764839108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424005543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":17,"alternative-id":["S0002939424005543"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.11.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suprachoroidal Triamcinolone Acetonide for Noninfectious Uveitis: Real-World Impact on Clinical Outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}